Mucormycosis: A killer in the shadow of COVID-19.

Suvvari, Tarun Kumar; Arigapudi, Nithya; Kandi, Venkata Ramana; Kutikuppala, Lv Simhachalam

Suvvari, Tarun Kumar; Arigapudi, Nithya; Kandi, Venkata Ramana; Kutikuppala, Lv Simhachalam.

Suvvari TK; Dr. N.T.R. University of Health Sciences, Vijayawada, Andhra Pradesh - 520004, India. Electronic address: tarunkumarsuvvari234@gmail.com.
Arigapudi N; Dr. N.T.R. University of Health Sciences, Vijayawada, Andhra Pradesh - 520004, India.
Kandi VR; Department of Microbiology, Prathima Institute of Medical Sciences, Karimnagar, India.
Kutikuppala LS; Dr. N.T.R. University of Health Sciences, Vijayawada, Andhra Pradesh - 520004, India.

J Mycol Med ; 31(3): 101161, 2021 Sep.

Article in English | MEDLINE | ID: covidwho-1253410

Subject(s)

COVID-19/complications; Immunocompromised Host; Mucormycosis/etiology; Antifungal Agents/therapeutic use; COVID-19/immunology; Diabetes Complications/immunology; Diabetes Complications/microbiology; Humans; Mucormycosis/complications; Mucormycosis/diagnosis; Mucormycosis/drug therapy; Risk Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunocompromised Host / COVID-19 / Mucormycosis Type of study: Diagnostic study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Mycol Med Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google